Skip to Main Content

Paper Details

Systemic treatment of metastatic hormone-sensitive prostate cancer-upfront triplet versus doublet combination therapy.
ESMO Open
2
2023
Author NameAffiliation
Robert G BristowCancer Research UK Manchester Institute, University of Manchester, Manchester Cancer Research Centre
  • 1 - 1

Datasets

Release 1.2